| Uchechukwu Ifeji, | |
|
11120 New Hampshire Ave Ste 501, Silver Spring, MD 20904-2618 | |
| (301) 593-8300 | |
| (301) 593-8301 |
| Full Name | Uchechukwu Ifeji |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 11120 New Hampshire Ave Ste 501, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043736846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R181434 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vesta, Inc. | 3678568375 | 22 |
| My Client Mental Health And Wellness Llc | 5092194316 | 3 |
| Vesta, Inc. | 3678568375 | 22 |
News Archive
A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.
Isis Pharmaceuticals, Inc. announced today results from a Phase 1 study with ISIS-TTRRx. The results demonstrated that treatment with ISIS-TTRRx produced dose-dependent statistically significant reductions of greater than 80 percent in transthyretin (TTR) protein.
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
› Verified 3 days ago
| Entity Name | Vesta, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790995017 PECOS PAC ID: 3678568375 Enrollment ID: O20050411001119 |
News Archive
A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.
Isis Pharmaceuticals, Inc. announced today results from a Phase 1 study with ISIS-TTRRx. The results demonstrated that treatment with ISIS-TTRRx produced dose-dependent statistically significant reductions of greater than 80 percent in transthyretin (TTR) protein.
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
› Verified 3 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140522000040 |
News Archive
A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.
Isis Pharmaceuticals, Inc. announced today results from a Phase 1 study with ISIS-TTRRx. The results demonstrated that treatment with ISIS-TTRRx produced dose-dependent statistically significant reductions of greater than 80 percent in transthyretin (TTR) protein.
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
› Verified 3 days ago
| Entity Name | My Client Mental Health And Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417694118 PECOS PAC ID: 5092194316 Enrollment ID: O20220616001867 |
News Archive
A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.
Isis Pharmaceuticals, Inc. announced today results from a Phase 1 study with ISIS-TTRRx. The results demonstrated that treatment with ISIS-TTRRx produced dose-dependent statistically significant reductions of greater than 80 percent in transthyretin (TTR) protein.
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Uchechukwu Ifeji, 11120 New Hampshire Ave Ste 5, Silver Spring, MD 20904-2633 Ph: (240) 838-0497 | Uchechukwu Ifeji, 11120 New Hampshire Ave Ste 501, Silver Spring, MD 20904-2618 Ph: (301) 593-8300 |
News Archive
A multi-institution study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that increasing the number of insured patients is not associated with higher intensive care unit (ICU) usage in Massachusetts.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.
Isis Pharmaceuticals, Inc. announced today results from a Phase 1 study with ISIS-TTRRx. The results demonstrated that treatment with ISIS-TTRRx produced dose-dependent statistically significant reductions of greater than 80 percent in transthyretin (TTR) protein.
A team of scientists from the United Kingdom has designed an experimental medicine trial to evaluate the safety/tolerability, and efficacy profiles of a panel of candidate repurposed therapies in coronavirus disease 2019 (COVID-19) patients. A detailed outline of the trial is currently available on the medRxiv* preprint server.
An approach based on artificial intelligence may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future.
› Verified 3 days ago
Mariama Keita, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10801 Lockwood Dr Ste 160, Silver Spring, MD 20901 Phone: 301-298-1040 | |
Mrs. Kelly Ann Mercado, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10801 Lockwood Dr, Suite 200, Silver Spring, MD 20901 Phone: 301-593-2002 | |
Antonia Forbin, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8500 New Hampshire Ave Apt 129, Silver Spring, MD 20903 Phone: 202-602-9803 | |
Ms. Deborah Ryan, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 240-364-2510 | |
Ms. Colleen Marie Healey, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 Forest Glen Rd, Kaiser Permanente Holy Cross Hospital, Silver Spring, MD 20910 Phone: 301-905-3600 | |
Vera Ogembo, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10801 Lockwood Dr, Suite 140, Silver Spring, MD 20901 Phone: 301-592-1780 Fax: 240-645-4013 | |
Giovanna Happy Tchouanto, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 |